Induction of differentiation of human promyelocytic leukemia (HL-60) cells by teleocidin and phorbol-12-myristate-13-acetate
- 1 January 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 3 (1) , 111-114
- https://doi.org/10.1093/carcin/3.1.111
Abstract
Human promyelocytic leukemia cells (HL-60) were induced to differentiate into macrophage-like cells in a dose-dependent manner by the tumor promoters phorbol-12-myristate-13-acetate and teleocidin, a non-phorbol ester promoter. An HL-60 cell variant, designated as R-59, which is resistant to differentiation induction by phorbol-12-myristate-13-acetate was also resistant to differentiation induction by teleocidin. Differentiation was determined by increases in the percent of morphologically mature cells and in lysozyme and nonspecific esterase activities. Both compounds inhibited the growth of HL-60 cells by blocking them from entering the synthesis phase of the cell cycle with an accumulation of cells after 48 h in G 1 phase. No such effects were observed in the R-59 cells. They were, however, as susceptible as the parent HL-60 cells, to inducers which are not considered to be tumor promoters such as dimethyl-sulfoxide and retinoic add. However, these inducers cause the HL-60 and R-59 cells to differentiate into granulocyte-like cells. These results indicate that teleocidin produces in both the HL-60 and R-59 cells effects which are similar to those caused by phorbol-12-myristate-13-acetate. The possibility that agents producing such effects in these two cell types may represent potential tumor promoters is discussed.This publication has 21 references indexed in Scilit:
- Multi-user system for analysis of data from flow cytometryComputer Programs in Biomedicine, 1979
- A possible naturally occurring tumor promoter, teleocidin B from StreptomycesBiochemical and Biophysical Research Communications, 1979
- Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotionProceedings of the National Academy of Sciences, 1979
- Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.Proceedings of the National Academy of Sciences, 1979
- Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents.Proceedings of the National Academy of Sciences, 1979
- MACROPHAGE-LIKE CELL-TRANSFORMATION AND CFU(C) FLUCTUATIONS IN NORMAL AND LEUKEMIC HUMAN MARROW CULTURES TREATED BY PHORBOL DIESTER1979
- Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemiaNature, 1978
- Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.Proceedings of the National Academy of Sciences, 1978
- Control of lysozyme induction in the differentiation of myeloid leukemic cellsCell, 1976
- A New Toxic Substance, Teleocidin, Produced byStreptomycesAgricultural and Biological Chemistry, 1962